Business

Johnson & Johnson puts up strong profit and revenue in 4Q

Posted January 22, 2019 6:00 am

The Associated Press

NEW BRUNSWICK, N.J. (AP) - Johnson & Johnson is reporting better than expected profit and revenue for the fourth quarter on strong sales of cancer treatments.

The company on Tuesday reported net income of $3.04 billion after a loss in the same period last year.

Per-share earnings were $1.12. Earnings, adjusted for one-time gains and costs, came to $1.97 per share, which is 2 cents better than industry analysts expected, according to a survey by Zacks Investment Research.

Revenue of $20.39 billion also edged out expectations.

Johnson & Johnson expects full-year earnings between $8.50 and $8.65 per share, with revenue between $80.4 billion and $81.2 billion.

_____

Portions of this story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JNJ at https://www.zacks.com/ap/JNJ

Article Comments

Article Categories
Business Content Providers Nation and World News

Article Comments

Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.